Screener
Dyne Therapeutics, Inc. DYN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | 10,781 | 8,082 |
| Accrued expenses and other current liabilities | 29,211 | 37,548 |
| Vendor financing arrangement | 6,224 | — |
| Lease liabilities | 5,033 | 4,995 |
| Total current liabilities | 51,249 | 50,625 |
| Long-term debt, net | 149,375 | 148,921 |
| Lease liabilities, net of current portion | 14,271 | 15,283 |
| Total liabilities | 214,895 | 214,829 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s operating lease liabilities (current)?
- Dyne Therapeutics, Inc. (DYN) reported operating lease liabilities (current) of $5.03M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Dyne Therapeutics, Inc.'s operating lease liabilities (current) decreased by 1.5% year-over-year, from $5.11M to $5.03M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Dyne Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude